Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests using natural remedies like bloodletting and honey for various health issues but lacks scientific evidence for their effectiveness.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Global oil use will rise, US corn-to-ethanol policy is flawed, and various social and economic issues need attention.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Minoxidil, propranolol, and furosemide effectively control severe hypertension, but may cause sodium retention.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Ozone therapy might improve cancer treatment and reduce its side effects.

Men with early-onset baldness have a higher chance of heart disease and clogged arteries.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

New guidelines stress early diagnosis and lifestyle changes to manage metabolic syndrome and prevent complications.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.